✦ LIBER ✦

Patients’ Willingness to Accept the Risks and Benefits of New Treatments for Chronic Hepatitis C Virus Infection

✍ Scribed by Kauf, Teresa L.; Mohamed, Ateesha F.; Hauber, A. Brett; Fetzer, Derek; Ahmad, Atiya

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Preliminary Benefit-Risk Assessment of

✍ Dr Fabien Zoulim 📂 Article 📅 2002 🏛 Springer International Publishing AG 🌐 English ⚖ 180 KB

Using surveillance data to determine tre

✍ Lattimore, Sam; Irving, Will; Collins, Sarah; Penman, Celia; Ramsay, Mary 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 673 KB

Interferon-induced retinopathy and its r

✍ J. D. PANETTA; N. GILANI 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Effectiveness of Interferon Treatment fo

✍ Misako Ohmiya; Jun Hayashi; Kumiko Ueno; Norihiro Furusyo; Yasunori Sawayama; Ya 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 71 KB

Risk factors for Hepatitis C virus (HCV)

✍ M. Peric; Z. Bosnjak; A. Antolovic-Pozgain; B. Sarkanj; S. Dzijan; D. Vukovic; N 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Guidelines for the treatment of chronic

✍ Hiromitsu Kumada; Takeshi Okanoue; Morikazu Onji; Hisataka Moriwaki; Namiki Izum 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB